CaleighFindley, PhD
Communications and Content Manager, BrightFocus Foundation
Biography
Caleigh has several years of experience in scientific writing and communications for research non-profits and pharmaceutical industry. She received her bachelor’s degree in psychology from the University of Colorado Colorado Springs, where she completed an honors thesis on the predictive efficacy of biomarkers and cognitive measures in Alzheimer’s disease. She then completed her doctoral degree in pharmacology and neuroscience at Southern Illinois University School of Medicine. Her dissertation examined neurotransmission and metabolic imbalances in Alzheimer’s disease.
She can be reached at cfindley@brightfocus.org.
Articles
Articles by
Caleigh Findley, PhD
New Blood Test Could Personalize Alzheimer’s Treatment Like Never Before
A new Alzheimer’s blood test may reveal how far the disease has progressed and identify who’s most likely to benefit from anti-amyloid therapies.
FDA Clears First Blood Test to Aid in Alzheimer’s Diagnosis
The Lumipulse G β-Amyloid Ratio (1-42/1-40) blood test, manufactured by Fujirebio Diagnostics, measures two forms of amyloid-beta in the blood.
Breaking News Dispatch: Alzheimer’s Drug Breakthroughs and Care Access Tools
Read the top headlines in Alzheimer’s clinical trials and healthcare platforms.